Lysostaphin Disrupts Staphylococcus aureus and Staphylococcus epidermidis Biofilms on Artificial Surfaces

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 11, 2003, Pages 3407-3414

  Wu, Julie A ^a,b   Kusuma, Caroline ^a   Mond, James J ^a   Kokai Kun, John F ^a  

^a Biosynexus Incorporated   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; GLYCYLGLYCINE; LYSOSTAPHIN; OXACILLIN; PEPTIDOGLYCAN; PROTEINASE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOFILM; CONTROLLED STUDY; DRUG EFFICACY; EXTRACELLULAR MATRIX; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURFACE PROPERTY;

ANTI-BACTERIAL AGENTS; BIOFILMS; LYSOSTAPHIN; METHICILLIN RESISTANCE; MICROSCOPY, ELECTRON, SCANNING; OXACILLIN; PENICILLINS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURFACE PROPERTIES; VANCOMYCIN;

EID: 0242354001     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.11.3407-3414.2003     Document Type: Article

References (42)

1. Amorena, B., E. Gracia, M. Monzón, J. Leiva, C. Oteiza, M. Pérez, J. Alabart, and J. Hernández-Yago. 1999. Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J. Antimicrob. Chemother. 44:43-55.
2. Bellón, J. M., N. G-Honduvilla, F. Jurado, A. G-Carranza, and J. Buján. 2001. In vitro interaction of bacteria with polypropylene/ePTFE prostheses. Biomaterials 22:2021-2024.
3. Browder, H., W. Zygmunt, J. Young, and P. Travormina. 1965. Lysostaphin: enzymatic mode of action. Biochem. Biophys. Res. Commun. 19:383-389.
4. Centers for Disease Control and Prevention. 1998. Preventing emerging infectious diseases: a strategy for the 21st century. Centers for Disease Control and Prevention, Atlanta, Ga.
5. Chamis, A., G. Peterson, C. Cabell, G. Corey, G. Sorrentino, R. Greenfield, R. Thomas, L. Reller, and V. Fowler. 2001. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 104:1029-1033.
6. Christensen, G. D., W. A. Simpson, J. J. Younger, L. M. Baddour, F. F. Barrett, D. M. Melton, and E. H. Beachey. 1985. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J. Clin. Microbiol. 22:996-1006.
7. Climo, M. W., K. Ehlert, and G. L. Archer. 2001. Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45:1431-1437.
8. Climo, M. W., R. L. Patron, B. P. Goldstein, and G. L. Archer. 1998. Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis. Antimicrob. Agents Chemother. 42:1355-1360.
9. Costerton, J. 1999. Introduction to biofilm. Int. J. Antimicrob. Agents 11:217-221.
10. Costerton, J., P. Stewart, and E. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections., Science 284:1318-1322.
11. Cucarella, C., C. Solano, J. Valle, B. Amorena, Í. Lasa, and J. R. Penadés. 2001. Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J. Bacteriol. 183:2888-2896.
12. Dajcs, J., E. Hume, J. Moreau, A. Caballero, B. Cannon, and R. O'Callaghan. 2000. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in rabbits. Investig. Ophthalmol. Vis. Sci. 41:1432-1437.
13. de Silva, G. D. I., M. Kantzanou, A. Justice, R. C. Massey, A. R. Wilkinson, N. P. J. Day, and S. J. Peacock. 2002. The ica operon and biofilm production in coagulase-negative staphylococci associated with carriage and disease in a neonatal intensive care unit. J. Clin. Microbiol. 40:382-388.
14. DiTizio, V., G. Feurguson, M. Mittleman, A. Khoury, A. Bruce, and F. DiCosmo. 1998. A liposomal hydrogel for the prevention of bacterial adhesion to catheters. Biomaterials 19:1877-1884.
15. Donlan, R. M., and J. W. Costerton. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193.
16. Donlan, R. M., R. Murga, M. Bell, C. M. Toscano, J. H. Carr, T. J. Novicki, C. Zuckerman, L. C. Corey, and J. M. Miller. 2001. Protocol for detection of biofilms on needleless connectors attached to central venous catheters. J. Clin. Microbiol. 39:750-753.
17. Dunne, W. M., Jr. 2002. Bacterial adhesion: seen any good biofilms lately? Clin. Microbiol. Rev. 15:155-166.
18. Gander, S., and R. Finch. 2000. The effects of exposure at constant (1 h) or exponentially decreasing concentrations of quinupristin/dalfopristin on biofilms of gram-positive bacteria. J. Antimicrob. Chemother. 46:61-67.
19. Gross, M., S. E. Cramton, F. Götz, and A. Peschel. 2001. Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces. Infect. Immun. 69:3423-3426.
20. Hamilton-Miller, J., and S. Shah. 1997. Activity of quinupristin/dalfopristin against Staphylococcus epidermidis in biofilms: a comparison with ciprofloxacin. J. Antimicrob. Chemother. 39:103-108.
21. Huber, M. M., and T. W. Huber. 1989. Susceptibility of methicillin-resistant Staphylococcus aureus to lysostaphin. J. Clin. Microbiol. 27:1122-1124.
22. Johansen, C., P. Falholt, and L. Gram. 1997. Enzymatic removal and disinfection of bacterial biofilms. Appl. Environ. Microbiol. 63:3724-3728.
23. Jones, S., M. Morgan, T. Humphrey, and H. Lappin-Scott. 2001. Effect of vancomycin and rifampicin on methicillin-resistant Staphylococcus aureus biofilms. Lancet 357:40-41.
24. Kerr, D., K. Plaut, A. Bramley, C. Williamson, A. Lax, K. Moore, K. Wells, and R. Wall. 2001. Lysostaphin expression in mammary glands confers protection against staphylococcal infection in transgenic mice. Nat. Biotechnol. 19:66-70.
25. Kiri, N., G. Archer, and M. W. Climo. 2002. Combinations of lysostaphin with β-lactams are synergistic against oxacillin-resistant Staphylococcus epidermidis. Antimicrob. Agents Chemother. 46:2017-2020.
26. Kokai-Kun, J. F., S. M. Walsh, T. Chanturiya, and J. J. Mond. 2003. Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model. Antimicrob. Agents Chemother. 47:1589-1597.
27. Lima, K., L. Fava, and J. Siqueira. 2001. Susceptibilities of Enterococcus faecalis biofilms to some antimicrobial medications. J. Endod. 27:616-619.
28. Mack, D., H. Rohde, S. Dobinsky, J. Riedewald, M. Nedelmann, J. K.-M. Knobloch, H.-A. Elsner, and H. H. Feucht. 2000. Identification of three essential regulatory gene loci governing expression of Staphylococcus epidermidis polysaccharide intercellular adhesion and biofilm formation. Infect. Immun. 68:3799-3807.
29. O'Grady, N., M. Alexander, E. Dellinger, J. Gerberding, S. Heard, D. Maki, H. Masur, R. McCormick, L. Mermel, M. Pearson, I. Raad, A. Randolph, and R. Weinstein. 2002. Guidelines for the prevention of intravascular catheter related infections. Pediatrics 110:e51.
30. Patron, R. L., M. W. Climo, B. P. Goldstein, and G. L. Archer. 1999. Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin. Antimicrob. Agents Chemother. 43:1754-1755.
31. Polonio, R. E., L. A. Mermel, G. E. Paquette, and J. F. Sperry. 2001. Eradication of biofilm-forming Staphylococcus epidermidis (RP62A) by a combination of sodium salicylate and vancomycin. Antimicrob. Agents Chemother. 45:3262-3266.
32. Raad, I., R. Darouiche, R. Hachem, D. Abi-Said, H. Safar, T. Darnule, M. Mansouri, and D. Morck. 1998. Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin. Crit. Care Med. 26:219-224.
33. B is involved in regulation of biofilm expression in a Staphylococcus aureus mucosal isolate. J. Bacteriol. 182:6824-6826.
34. Rachid, S., K. Ohlsen, W. Witte, J. Hacker, and W. Ziebuhr. 2000. Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesion expression in biofilm-forming Staphylococcus epidermidis. Antimicrob. Agents Chemother. 44:3357-3363.
35. Ramerez de Arellano, E., A. Pascual, L. Martinez-Martinez, and E. Perea. 1994. Activity of eight antibacterial agents on Staphylococcus epidermidis attached to Teflon catheters. J. Med. Microbiol. 10:43-47.
36. Rupp, M., and K. Hamer. 1998. Effect of subinhibitory concentrations of vancomycin, cefazolin, ofloxacin, L-ofloxacin and D-ofloxacin on adherence to intravascular catheters and biofilm formation by Staphylococcus epidermidis. J. Antimicrob. Chemother. 41:155-161.
37. Schierholz, J., H. Steinhauser, A. Rump, R. Berkels, and G. Pulverer. 1997. Controlled release of antibiotics from biomedical polyurethanes: morphological and structural features. Biomaterials 18:839-844.
38. Schindler, C., and V. Schuhardt. 1964. Lysostaphin: a new bacteriolytic agent for the Staphylococcus. Proc. Natl. Acad. Sci. USA 51:414-421.
39. Sugita, J., N. Yokoi, N. Fullwood, A. Quantock, Y. Takada, Y. Nakamura, and S. Kinoshita. 2001. The detection of bacteria and bacterial biofilms in punctal plug holes. Cornea 20:362-365.
40. Whitchurch, C., T. Tolker-Nielsen, P. Ragas, and J. Mattick. 2002. Extracellular DNA required for bacterial biofilm formation. Science 295:1487.
41. Zekeriya, I., R. Darouiche, G. Landon, and T. Beck. 1996. Efficacy of antibiotics alone for orthopedic device related infections. Clin. Orthop. Relat. Res. 332:184-189.
42. Zygmunt, W., and P. Tavormina. 1972. Lysostaphin: model for specific enzymatic approach to infectious disease. Prog. Drug Res. 16:309-333.